{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:09:36Z","timestamp":1789614576180,"version":"build-2803163510"},"reference-count":250,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"am","delay-in-days":310,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01 HL135455"],"award-info":[{"award-number":["K01 HL135455"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["869015"],"award-info":[{"award-number":["869015"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL145676"],"award-info":[{"award-number":["R01 HL145676"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL130020"],"award-info":[{"award-number":["R01 HL130020"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL146690"],"award-info":[{"award-number":["R01 HL146690"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL158641"],"award-info":[{"award-number":["R01 HL158641"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL161002"],"award-info":[{"award-number":["R01 HL161002"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.yjmcc.2025.09.008","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:35:39Z","timestamp":1759282539000},"page":"37-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Decoding long COVID-associated cardiovascular dysfunction: Mechanisms, models, and new approach methodologies"],"prefix":"10.1016","volume":"209","author":[{"given":"Dilip","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazish","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.yjmcc.2025.09.008_bb0005","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S2213-2600(22)00135-7","article-title":"Long COVID: aiming for a consensus","volume":"10","author":"Munblit","year":"2022","journal-title":"Lancet Respir. Med."},{"issue":"22","key":"10.1016\/j.yjmcc.2025.09.008_bb0010","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2023.8823","article-title":"Development of a definition of postacute sequelae of SARS-CoV-2 infection","volume":"329","author":"Thaweethai","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"eClinicalMedicine"},{"issue":"16","key":"10.1016\/j.yjmcc.2025.09.008_bb0020","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/jama.2022.18931","article-title":"Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021","volume":"328","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.yjmcc.2025.09.008_bb0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7985","key":"10.1016\/j.yjmcc.2025.09.008_bb0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.yjmcc.2025.09.008_bb0035","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/jcm12041413","article-title":"Vascular function, systemic inflammation, and coagulation activation 18 months after COVID-19 infection: An observational cohort study","volume":"12","author":"Willems","year":"2023","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb0040","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/s44161-024-00543-8","article-title":"CCL2-mediated endothelial injury drives cardiac dysfunction in long COVID","volume":"3","author":"Thomas","year":"2024","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.746021","article-title":"Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection","volume":"12","author":"Patterson","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1053\/j.gastro.2022.04.037","article-title":"Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases","volume":"163","author":"Zollner","year":"2022","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0055","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gutjnl-2021-325989","article-title":"Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"issue":"6680","key":"10.1016\/j.yjmcc.2025.09.008_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7942","article-title":"Persistent complement dysregulation with signs of thromboinflammation in active Long Covid","volume":"383","author":"Cervia-Hasler","year":"2024","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb0065","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s44161-023-00336-5","article-title":"SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels","volume":"2","author":"Eberhardt","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"issue":"8031","key":"10.1016\/j.yjmcc.2025.09.008_bb0070","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41586-024-07873-4","article-title":"Fibrin drives thromboinflammation and neuropathology in COVID-19","volume":"633","author":"Ryu","year":"2024","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb0075","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.it.2024.09.003","article-title":"COVID-19 thromboinflammation: adding inflammatory fibrin to the puzzle","volume":"45","author":"Magrini","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0080","series-title":"Long COVID in Adults: United States, 2022","year":"2023"},{"issue":"10343","key":"10.1016\/j.yjmcc.2025.09.008_bb0085","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0140-6736(22)00941-2","article-title":"Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2","volume":"399","author":"Antonelli","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijid.2023.10.022","article-title":"Long-term prognosis at 1.5 years after infection with wild-type strain of SARS-CoV-2 and alpha, Delta, as well as omicron variants","volume":"137","author":"Agergaard","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0095","article-title":"Long COVID facts and findings: a large-scale online survey in 74,075 Chinese participants","volume":"52","author":"Qin","year":"2024","journal-title":"Lancet Reg. Health - Western Pacific"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12916-025-03908-3","article-title":"Prevalence of cardiovascular symptoms in post-acute COVID-19 syndrome: a meta-analysis","volume":"23","author":"Huang","year":"2025","journal-title":"BMC Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb0105","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s11606-022-07997-1","article-title":"Racial\/ethnic disparities in post-acute sequelae of SARS-CoV-2 infection in New York: an EHR-based cohort study from the RECOVER program","volume":"38","author":"Khullar","year":"2023","journal-title":"J. Gen. Intern. Med."},{"issue":"7","key":"10.1016\/j.yjmcc.2025.09.008_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110257","article-title":"Advancing health equity in the aftermath of COVID-19: confronting intensifying racial disparities","volume":"27","author":"Prentice","year":"2024","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2213-2600(23)00414-9","article-title":"The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia","volume":"12","author":"Catal\u00e0","year":"2024","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0120","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1038\/s41467-024-48022-9","article-title":"Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection","volume":"15","author":"Malden","year":"2024","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.09.008_bb0125","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(22)00126-6","article-title":"Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study","volume":"10","author":"Huang","year":"2022","journal-title":"Lancet Respir. Med."},{"issue":"11","key":"10.1016\/j.yjmcc.2025.09.008_bb0130","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.42106","article-title":"Post\u2013COVID-19 symptoms 2 years after SARS-CoV-2 infection among hospitalized vs nonhospitalized patients","volume":"5","author":"Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0135","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1038\/s41467-022-30836-0","article-title":"Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records","volume":"13","author":"Thompson","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.09.008_bb0140","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1176\/appi.neuropsych.21070193","article-title":"Post-acute sequelae of SARS-CoV-2 infection: a descriptive clinical study","volume":"34","author":"Gutierrez-Martinez","year":"2022","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae027","article-title":"Two-year longitudinal study reveals that long COVID symptoms peak and quality of life nadirs at 6\u201312 months postinfection","volume":"11","author":"Demko","year":"2024","journal-title":"Open Forum Infect. Dis."},{"issue":"11","key":"10.1016\/j.yjmcc.2025.09.008_bb0150","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","article-title":"Acute and postacute sequelae associated with SARS-CoV-2 reinfection","volume":"28","author":"Bowe","year":"2022","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.yjmcc.2025.09.008_bb0155","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after breakthrough SARS-CoV-2 infection","volume":"28","author":"Al-Aly","year":"2022","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048391","article-title":"Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study","volume":"11","author":"Dennis","year":"2021","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/01410768231154703","article-title":"Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study","volume":"116","author":"Dennis","year":"2023","journal-title":"J. R. Soc. Med."},{"issue":"674","key":"10.1016\/j.yjmcc.2025.09.008_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm9151","article-title":"SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages","volume":"14","author":"Mart\u00ednez-Col\u00f3n","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.09.008_bb0175","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S1473-3099(24)00171-3","article-title":"The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China","volume":"24","author":"Zuo","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.09.008_bb0180","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/cid\/ciab465","article-title":"Circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients","volume":"74","author":"Ogata","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0185","article-title":"Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19","volume":"95","author":"Schulthei\u00df","year":"2023","journal-title":"J M\u00e9d Virol."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb0190","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s41590-023-01601-2","article-title":"SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)","volume":"24","author":"Proal","year":"2023","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0195","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jamainternmed.2023.0743","article-title":"Association of Treatment with Nirmatrelvir and the risk of post\u2013COVID-19 condition","volume":"183","author":"Xie","year":"2023","journal-title":"JAMA Intern. Med."},{"issue":"13","key":"10.1016\/j.yjmcc.2025.09.008_bb0200","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJMoa2309003","article-title":"Nirmatrelvir for vaccinated or unvaccinated adult outpatients with Covid-19","volume":"390","author":"Hammond","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.09.008_bb0205","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jamainternmed.2024.2007","article-title":"Nirmatrelvir-ritonavir and symptoms in adults with Postacute sequelae of SARS-CoV-2 infection","volume":"184","author":"Geng","year":"2024","journal-title":"JAMA Intern. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0210","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.1765","article-title":"COVID-19 rebound after VV116 vs Nirmatrelvir-ritonavir treatment","volume":"7","author":"Yang","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajem.2023.09.051","article-title":"Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: a report of signal index cases and call for targeted research","volume":"75","author":"Scheppke","year":"2024","journal-title":"Am. J. Emerg. Med."},{"issue":"35","key":"10.1016\/j.yjmcc.2025.09.008_bb0220","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1016\/j.vaccine.2023.07.011","article-title":"Impact of COVID vaccine and comorbidities in patients receiving casirivimab-imdevimab monoclonal antibody during SARS-CoV-2 B.1.617.2 (Delta) surge: a real-world study","volume":"41","author":"Agrawal","year":"2023","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb0225","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S1473-3099(22)00416-9","article-title":"Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial","volume":"22","author":"Herman","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0230","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12916-024-03328-9","article-title":"Incidence of new-onset hypertension before, during, and after the COVID-19 pandemic: a 7-year longitudinal cohort study in a large population","volume":"22","author":"Trimarco","year":"2024","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0235","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12879-022-07153-4","article-title":"Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19","volume":"22","author":"Tejerina","year":"2022","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0240","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciac722","article-title":"Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae","volume":"76","author":"Swank","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.yjmcc.2025.09.008_bb0245","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.3390\/v13122376","article-title":"Systemic inflammation and complement activation parameters predict clinical outcome of severe SARS-CoV-2 infections","volume":"13","author":"Huber","year":"2021","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.yjmcc.2025.09.008_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.01.053","article-title":"COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas","volume":"184","author":"Ren","year":"2021","journal-title":"Cell"},{"issue":"6508","key":"10.1016\/j.yjmcc.2025.09.008_bb0255","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb0260","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Valle","year":"2020","journal-title":"Nat. Med."},{"issue":"10223","key":"10.1016\/j.yjmcc.2025.09.008_bb0265","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.yjmcc.2025.09.008_bb0270","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/infdis\/jiab490","article-title":"Markers of immune activation and inflammation in individuals with Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection","volume":"224","author":"Peluso","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb0275","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41577-023-00904-7","article-title":"The immunology of long COVID","volume":"23","author":"Altmann","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0280","article-title":"The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Schulthei\u00df","year":"2022","journal-title":"Cell Rep Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105880","article-title":"Early T cell responses correlate with SARS-CoV-2 viral clearance","volume":"119","author":"Koutsakos","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0295","doi-asserted-by":"crossref","first-page":"1151780","DOI":"10.3389\/fimmu.2023.1151780","article-title":"Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals","volume":"14","author":"Park","year":"2023","journal-title":"Front. Immunol."},{"issue":"57","key":"10.1016\/j.yjmcc.2025.09.008_bb0300","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg6461","article-title":"SARS-CoV-2 mutations in MHC-I\u2013restricted epitopes evade CD8+ T cell responses","volume":"6","author":"Agerer","year":"2021","journal-title":"Sci Immunol."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0305","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2567.1997.00258.x","article-title":"Regulation of HLA class I and II expression by interferons and influenza a virus in human peripheral blood mononuclear cells","volume":"91","author":"Keskinen","year":"1997","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0310","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1038\/s41467-022-35638-y","article-title":"Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19","volume":"13","author":"Maher","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.yjmcc.2025.09.008_bb0315","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","article-title":"Considering how biological sex impacts immune responses and COVID-19 outcomes","volume":"20","author":"Scully","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.09.008_bb0320","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","article-title":"Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or Long COVID: a Meta-analysis and systematic review","volume":"226","author":"Chen","year":"2022","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb0325","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1089\/jwh.2021.0411","article-title":"Sex-related differences in Long-COVID-19 syndrome","volume":"31","author":"Pel\u00e0","year":"2022","journal-title":"J. Women\u2019s Health"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0330","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1186\/s12879-021-06313-2","article-title":"Sex-based clinical and immunological differences in COVID-19","volume":"21","author":"Huang","year":"2021","journal-title":"BMC Infect. Dis."},{"issue":"11","key":"10.1016\/j.yjmcc.2025.09.008_bb0335","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac618","article-title":"Predictors of SARS-CoV-2 RNA from nasopharyngeal swabs and concordance with other compartments in nonhospitalized adults with mild to moderate COVID-19","volume":"9","author":"Moser","year":"2022","journal-title":"Open Forum Infect. Dis."},{"issue":"773","key":"10.1016\/j.yjmcc.2025.09.008_bb0340","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adr1032","article-title":"Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution","volume":"16","author":"Hamlin","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb0345","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.yjmcc.2025.09.008_bb0350","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0355","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb0360","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/his.14134","article-title":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction","volume":"77","author":"Menter","year":"2020","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb0365","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMc2033369","article-title":"Microvascular injury in the brains of patients with Covid-19","volume":"384","author":"Lee","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb0370","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0375","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57555","article-title":"Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome","volume":"9","author":"van de Veerdonk","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106826","article-title":"A new storm on the horizon in COVID-19: bradykinin-induced vascular complications","volume":"137","author":"McCarthy","year":"2021","journal-title":"Vasc. Pharmacol."},{"issue":"23","key":"10.1016\/j.yjmcc.2025.09.008_bb0385","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01396-21","article-title":"Direct activation of endothelial cells by SARS-CoV-2 Nucleocapsid protein is blocked by simvastatin","volume":"95","author":"Qian","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.776861","article-title":"Emerging role of platelet-endothelium interactions in the pathogenesis of severe SARS-CoV-2 infection-associated myocardial injury","volume":"13","author":"Rossouw","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.09.008_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0400","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2021.11.027","article-title":"Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19","volume":"209","author":"Willems","year":"2022","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0405","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCRESAHA.121.319060","article-title":"An Immuno-cardiac model for macrophage-mediated inflammation in COVID-19 hearts","volume":"129","author":"Yang","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109325","article-title":"Role of CCL2\/CCR2 axis in the pathogenesis of COVID-19 and possible treatments: all options on the table","volume":"113","author":"Ranjbar","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"375","key":"10.1016\/j.yjmcc.2025.09.008_bb0415","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4923","article-title":"Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension","volume":"9","author":"Kossmann","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0420","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb0425","article-title":"COVID-19 causes Ferroptosis and oxidative stress in human endothelial cells","volume":"12","author":"Jankauskas","year":"2023","journal-title":"Antioxidants (Basel)."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106486","article-title":"Endothelial dysfunction in long-COVID: new insights from the nationwide multicenter LINCOLN study","volume":"185","author":"Trimarco","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0435","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/jpet.122.001253","article-title":"Endothelial extracellular vesicles enriched in microRNA-34a predict new-onset diabetes in coronavirus disease 2019 (COVID-19) patients: novel insights for Long COVID metabolic sequelae","volume":"389","author":"Mone","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"21","key":"10.1016\/j.yjmcc.2025.09.008_bb0440","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183777","article-title":"A six-year study in a real-world population reveals an increased incidence of dyslipidemia during COVID-19","volume":"134","author":"Trimarco","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0445","doi-asserted-by":"crossref","first-page":"120389","DOI":"10.1016\/j.atherosclerosis.2025.120389","article-title":"Impact of severe COVID-19 infection on coronary microvascular dysfunction in ANOCA patients: a cross-sectional study","volume":"407","author":"Aldujeli","year":"2025","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb0450","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/jcm9051417","article-title":"Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence","volume":"9","author":"Sardu","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0455","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2021.01.021","article-title":"Familial hypercholesterolaemia and COVID-19: a two-hit scenario for endothelial dysfunction amenable to treatment","volume":"320","author":"Vuorio","year":"2021","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0460","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.3390\/ijms24065514","article-title":"The long term residual effects of COVID-associated coagulopathy","volume":"24","author":"Ranucci","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.yjmcc.2025.09.008_bb0465","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/bmm-2022-0050","article-title":"Association between D-dimer levels and post-acute sequelae of Sars-Cov-2 in patients from a tertiary care center","volume":"16","author":"Kalaivani","year":"2022","journal-title":"Biomark. Med"},{"issue":"7","key":"10.1016\/j.yjmcc.2025.09.008_bb0470","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/ajh.26575","article-title":"Hypercoagulability, endotheliopathy, and inflammation approximating 1year after recovery: assessing the long-term outcomes in COVID-19 patients","volume":"97","author":"Fan","year":"2022","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0475","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","article-title":"Persistent clotting protein pathology in Long COVID\/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin","volume":"20","author":"Pretorius","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"issue":"10294","key":"10.1016\/j.yjmcc.2025.09.008_bb0480","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.yjmcc.2025.09.008_bb0485","article-title":"Comparison of the coagulopathies associated with COVID-19 and sepsis. Research and practice","volume":"5","author":"Campbell","year":"2021","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0490","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.thromres.2021.05.016","article-title":"Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19","volume":"204","author":"Stanne","year":"2021","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.09.008_bb0495","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/MBC.0000000000001070","article-title":"Relationship between serum soluble endothelial protein C receptor level and COVID-19 findings","volume":"32","author":"Bayrakci","year":"2021","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"Supplement 1","key":"10.1016\/j.yjmcc.2025.09.008_bb0500","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1182\/blood-2020-141872","article-title":"Defibrotide for the treatment of Endotheliitis complicating Sars-Cov-2 infection: rationale and ongoing studies as part of the international Defacovid study group","volume":"136","author":"Moraleda","year":"2020","journal-title":"Blood"},{"issue":"10319","key":"10.1016\/j.yjmcc.2025.09.008_bb0505","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(21)02392-8","article-title":"Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial","volume":"399","author":"Ramacciotti","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0510","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s10020-022-00548-8","article-title":"Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism","volume":"28","author":"Patel","year":"2022","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0515","article-title":"Vascular alterations among young adults with SARS-CoV-2","volume":"320","author":"Ratchford","year":"2021","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0520","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cvr\/cvab339","article-title":"Prolonged endothelial-dysfunction in human arterioles following infection with SARS-CoV-2","volume":"118","author":"Nishijima","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0525","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10456-022-09850-9","article-title":"Persistent capillary rarefication in long COVID syndrome","volume":"26","author":"Osiaevi","year":"2023","journal-title":"Angiogenesis"},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2023.107250","article-title":"Sex differences in vascular endothelial function related to acute and long COVID-19","volume":"154","author":"Kitselman","year":"2024","journal-title":"Vasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0535","first-page":"L1280","article-title":"Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells","volume":"318","author":"Stelzig","year":"2020","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"6578","key":"10.1016\/j.yjmcc.2025.09.008_bb0540","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1126\/science.abm2052","article-title":"Nervous system consequences of COVID-19","volume":"375","author":"Spudich","year":"2022","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb0545","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","article-title":"Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study","volume":"7","author":"Varatharaj","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0550","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","article-title":"Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis","volume":"101","author":"Ceban","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb0555","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-220717","article-title":"Association of COVID-19 with new-onset Alzheimer\u2019s disease","volume":"89","author":"Wang","year":"2022","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0560","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/s41467-022-29440-z","article-title":"Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates","volume":"13","author":"Rutkai","year":"2022","journal-title":"Nat. Commun."},{"issue":"7941","key":"10.1016\/j.yjmcc.2025.09.008_bb0565","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","article-title":"SARS-CoV-2 infection and persistence in the human body and brain at autopsy","volume":"612","author":"Stein","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0570","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41593-020-00771-8","article-title":"The S1 protein of SARS-CoV-2 crosses the blood\u2013brain barrier in mice","volume":"24","author":"Rhea","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb0575","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S2215-0366(22)00260-7","article-title":"Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1&#x2008;284&#x2008;437 patients","volume":"9","author":"Taquet","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0580","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.120.031971","article-title":"Ischemic stroke, inflammation, and endotheliopathy in COVID-19 patients","volume":"52","author":"McAlpine","year":"2021","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.yjmcc.2025.09.008_bb0585","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: a post-mortem case series","volume":"19","author":"Matschke","year":"2020","journal-title":"Lancet Neurol."},{"issue":"754","key":"10.1016\/j.yjmcc.2025.09.008_bb0590","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk3295","article-title":"Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection","volume":"16","author":"Peluso","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"7821","key":"10.1016\/j.yjmcc.2025.09.008_bb0595","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2023.06.010","article-title":"High incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with Long COVID: implications for management and health care planning","volume":"138","author":"Seeley","year":"2025","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0605","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001146","article-title":"Peripheral neuropathy evaluations of patients with prolonged Long COVID","volume":"9","author":"Oaklander","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0610","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fneur.2022.1012668","article-title":"Characterization of autonomic symptom burden in long COVID: a global survey of 2,314 adults","volume":"13","author":"Larsen","year":"2022","journal-title":"Front. Neurol."},{"issue":"11","key":"10.1016\/j.yjmcc.2025.09.008_bb0615","first-page":"156","article-title":"Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: what do we know?","volume":"8","author":"Bisaccia","year":"2021","journal-title":"J. Cardiovasc. Develop. Dis."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0620","article-title":"Value of 123I-MIBG SPECT for the assessment of dysautonomia in patients with long COVID","volume":"52","author":"Xavier de Brito","year":"2024","journal-title":"IJC Heart Vasc."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0625","series-title":"Clinical, Biological and Molecular Aspects of COVID-19","first-page":"325","article-title":"Cardiac injury in COVID-19: A systematic review","author":"Moayed","year":"2021"},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0630","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13532","article-title":"Cardiac troponin and COVID-19 severity: results from BIOCOVID study","volume":"51","author":"Garc\u00eda de Guadiana-Romualdo","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"issue":"19","key":"10.1016\/j.yjmcc.2025.09.008_bb0635","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/eurheartj\/ehaa388","article-title":"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in northern Italy","volume":"41","author":"Inciardi","year":"2020","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0640","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.120.050543","article-title":"Myocardial injury in severe COVID-19 compared with non\u2013COVID-19 acute respiratory distress syndrome","volume":"143","author":"Metkus","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb0645","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.pcad.2020.05.013","article-title":"Special article - acute myocardial injury in patients hospitalized with COVID-19 infection: a review","volume":"63","author":"Bavishi","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"11","key":"10.1016\/j.yjmcc.2025.09.008_bb0650","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S2213-2600(21)00383-0","article-title":"Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study","volume":"9","author":"Evans","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb0655","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacc.2020.06.007","article-title":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection","volume":"76","author":"Lala","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb0660","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/RTI.0000000000000574","article-title":"Cardiac magnetic resonance imaging in coronavirus disease 2019 (COVID-19): a systematic review of cardiac magnetic resonance imaging findings in 199 patients","volume":"36","author":"Ojha","year":"2021","journal-title":"J. Thorac. Imaging"},{"issue":"19","key":"10.1016\/j.yjmcc.2025.09.008_bb0665","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/eurheartj\/ehab075","article-title":"Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance","volume":"42","author":"Kotecha","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2020.107300","article-title":"Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations","volume":"50","author":"Halushka","year":"2021","journal-title":"Cardiovasc. Pathol."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb0675","article-title":"Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection","volume":"319","author":"Robinson","year":"2020","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0680","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","article-title":"The signal pathways and treatment of cytokine storm in COVID-19","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0685","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12968-021-00798-1","article-title":"Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: a case\u2013control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC)","volume":"23","author":"Clark","year":"2021","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.09.008_bb0690","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3390\/jcm12041536","article-title":"Cardiopulmonary long-term sequelae in patients after severe COVID-19 disease","volume":"12","author":"Niebauer","year":"2023","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.yjmcc.2025.09.008_bb0695","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.jcmg.2021.04.011","article-title":"Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers","volume":"14","author":"Joy","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0700","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/ehjci\/jeab268","article-title":"Progressive left and right heart dysfunction in coronavirus disease-19: prospective echocardiographic evaluation","volume":"23","author":"Chaturvedi","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Imag."},{"issue":"10393","key":"10.1016\/j.yjmcc.2025.09.008_bb0705","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S0140-6736(23)00810-3","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"401","author":"Huang","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0710","first-page":"38","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","author":"Davis","year":"2021","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0715","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s44325-024-00011-z","article-title":"Risk factors for long-term cardiovascular post-acute sequelae of COVID-19 infection: a nested case-control study in Hong Kong","volume":"1","author":"Yu","year":"2024","journal-title":"Npj Cardiovasc. Health"},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0720","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/joim.13070","article-title":"Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk","volume":"287","author":"Vuorio","year":"2020","journal-title":"J. Intern. Med."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.09.008_bb0725","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1007\/s11606-022-07523-3","article-title":"Factors associated with post-acute sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse cohort","volume":"37","author":"Yoo","year":"2022","journal-title":"J. Gen. Intern. Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb0730","article-title":"Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: a case control study","volume":"85","author":"Wan","year":"2022","journal-title":"J. Inf. Secur."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0735","article-title":"Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort","volume":"2","author":"Viet-Thi","year":"2023","journal-title":"BMJ Med."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0740","first-page":"53","article-title":"Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review","author":"Notarte","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb0745","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/jamacardio.2021.2828","article-title":"Patients with acute myocarditis following mRNA COVID-19 vaccination","volume":"6","author":"Kim","year":"2021","journal-title":"JAMA Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0750","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb0755","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41569-021-00662-w","article-title":"Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms","volume":"19","author":"Heymans","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.bja.2020.12.020","article-title":"Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?","volume":"126","author":"Garvey","year":"2021","journal-title":"Br. J. Anaesth."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.09.008_bb0765","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/diagnostics11091647","article-title":"Myocardial pathology in COVID-19-associated cardiac injury: a systematic review","volume":"11","author":"Maiese","year":"2021","journal-title":"Diagnostics"},{"issue":"19","key":"10.1016\/j.yjmcc.2025.09.008_bb0770","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/eurheartj\/ehaa311","article-title":"Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts","volume":"41","author":"Nicin","year":"2020","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.yjmcc.2025.09.008_bb0775","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20209610","article-title":"The protein expression profile of ACE2 in human tissues","volume":"16","author":"Hikmet","year":"2020","journal-title":"Mol. Syst. Biol."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb0780","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1002\/ehf2.13528","article-title":"Cardiovascular ACE2 receptor expression in patients undergoing heart transplantation","volume":"8","author":"Bargehr","year":"2021","journal-title":"ESC Heart Failure."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0785","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12933-021-01286-7","article-title":"Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte","volume":"20","author":"D\u2019Onofrio","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103182","article-title":"SARS-CoV-2 leads to a small vessel endotheliitis in the heart","volume":"63","author":"Maccio","year":"2021","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb0795","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145027","article-title":"Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2\u2013induced systemic toxicity","volume":"6","author":"Li","year":"2021","journal-title":"JCI Insight"},{"issue":"7866","key":"10.1016\/j.yjmcc.2025.09.008_bb0800","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0805","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28864","article-title":"Overview of autoantibodies in COVID-19 convalescents","volume":"95","author":"Dobrowolska","year":"2023","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb0810","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/cvr\/cvad174","article-title":"Proinflammatory cytokines driving cardiotoxicity in COVID-19","volume":"120","author":"Colzani","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0815","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab156","article-title":"Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients","volume":"8","author":"Ong","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0820","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1056506","article-title":"Persistence of inflammatory and vascular mediators 5 months after hospitalization with COVID-19 infection","volume":"10","author":"Melhorn","year":"2023","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb0825","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0830","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074572","article-title":"Molnupiravir and risk of post-acute sequelae of covid-19: cohort study","volume":"381","author":"Xie","year":"2023","journal-title":"BMJ"},{"issue":"7865","key":"10.1016\/j.yjmcc.2025.09.008_bb0835","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-021-03570-8","article-title":"COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets","volume":"595","author":"Delorey","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0840","article-title":"Single-nuclei characterization of pervasive transcriptional signatures across organs in response to COVID-19","volume":"12","author":"The","year":"2023","journal-title":"eLife"},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb0845","first-page":"109","article-title":"Human cardiac Pericytes are susceptible to SARS-CoV-2 infection","volume":"8","author":"Brumback","year":"2023","journal-title":"JACC: Basic Transl. Sci."},{"issue":"15","key":"10.1016\/j.yjmcc.2025.09.008_bb0850","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/cvr\/cvac097","article-title":"Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature","volume":"118","author":"Khan","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0855","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.thromres.2021.06.003","article-title":"C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: a retrospective study","volume":"204","author":"Nieri","year":"2021","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0860","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.123.066433","article-title":"Virus-induced acute respiratory distress syndrome causes cardiomyopathy through eliciting inflammatory responses in the heart","volume":"150","author":"Grune","year":"2024","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101695","article-title":"The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin \u03b15\u03b21 and NF-\u03baB signaling","volume":"298","author":"Robles","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102099","article-title":"Therapeutic application of estrogen for COVID-19: attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells","volume":"46","author":"Youn","year":"2021","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0875","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/cvr\/cvad191","article-title":"SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?","volume":"120","author":"Lui","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.09.008_bb0880","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","article-title":"COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives","volume":"17","author":"Nishiga","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0885","article-title":"Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection","volume":"10","author":"Adriana","year":"2023","journal-title":"Open Heart."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0890","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCULATIONAHA.122.062672","article-title":"Long COVID-19 cardiac complications are associated with autoimmunity to cardiac self-antigens sufficient to cause cardiac dysfunction","volume":"148","author":"Cremonesi","year":"2023","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb0895","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2239952","article-title":"Host genetic polymorphisms involved in long-term symptoms of COVID-19","volume":"12","author":"Udomsinprasert","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb0900","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41588-025-02100-w","article-title":"Genome-wide association study of long COVID","volume":"57","author":"Lammi","year":"2025","journal-title":"Nat. Genet."},{"issue":"7830","key":"10.1016\/j.yjmcc.2025.09.008_bb0905","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2787-6","article-title":"Animal models for COVID-19","volume":"586","author":"Mu\u00f1oz-Fontela","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.yjmcc.2025.09.008_bb0910","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41592-022-01447-w","article-title":"Animal models in SARS-CoV-2 research","volume":"19","author":"Chu","year":"2022","journal-title":"Nat. Methods"},{"issue":"7818","key":"10.1016\/j.yjmcc.2025.09.008_bb0915","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","article-title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice","volume":"583","author":"Bao","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.05.020","article-title":"A mouse model of SARS-CoV-2 infection and pathogenesis","volume":"28","author":"Sun","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"7830","key":"10.1016\/j.yjmcc.2025.09.008_bb0925","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","article-title":"A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures","volume":"586","author":"Dinnon","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.yjmcc.2025.09.008_bb0930","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41590-020-0794-2","article-title":"Publisher correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","author":"Winkler","year":"2020","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb0935","article-title":"SARS-CoV-2 infection downregulates myocardial ACE2 and potentiates cardiac inflammation in humans and hamsters","volume":"323","author":"Viveiros","year":"2022","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"6604","key":"10.1016\/j.yjmcc.2025.09.008_bb0940","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.abn8939","article-title":"Pathogenicity, transmissibility, and fitness of SARS-CoV-2 omicron in Syrian hamsters","volume":"377","author":"Yuan","year":"2022","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.yjmcc.2025.09.008_bb0945","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049632","article-title":"Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models","volume":"15","author":"Jeong","year":"2022","journal-title":"Dis. Model. Mech."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.09.008_bb0950","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/cid\/ciaa325","article-title":"Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a Golden Syrian Hamster model: implications for disease pathogenesis and transmissibility","volume":"71","author":"Chan","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb0955","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/cvr\/cvaa191","article-title":"Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart","volume":"116","author":"Liu","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb0960","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/s12276-024-01197-z","article-title":"Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis","volume":"56","author":"Jeong","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb0965","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.stemcr.2021.02.008","article-title":"SARS-CoV-2 infects human pluripotent stem cell-derived cardiomyocytes, impairing electrical and mechanical function","volume":"16","author":"Marchiano","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.09.008_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.03.026","article-title":"BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection","volume":"184","author":"Mills","year":"2021","journal-title":"Cell"},{"issue":"47","key":"10.1016\/j.yjmcc.2025.09.008_bb0975","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc3582","article-title":"TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes","volume":"5","author":"Zang","year":"2020","journal-title":"Sci. Immunol."},{"issue":"47","key":"10.1016\/j.yjmcc.2025.09.008_bb0980","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109905118","article-title":"Furin cleavage of the SARS-CoV-2 spike is modulated by <i>O<\/i>\u2212glycosylation","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102420","article-title":"Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2","volume":"24","author":"Saccon","year":"2021","journal-title":"iScience"},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb0990","doi-asserted-by":"crossref","DOI":"10.15252\/embj.20105114","article-title":"SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells","volume":"39","author":"Lukassen","year":"2020","journal-title":"EMBO J."},{"issue":"16","key":"10.1016\/j.yjmcc.2025.09.008_bb0995","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2119680119","article-title":"SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13","volume":"119","author":"Morrison","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"18","key":"10.1016\/j.yjmcc.2025.09.008_bb1000","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.jacc.2016.01.083","article-title":"Translation of human-induced pluripotent stem cells: from clinical trial in a dish to precision medicine","volume":"67","author":"Sayed","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.09.008_bb1005","doi-asserted-by":"crossref","DOI":"10.1242\/dev.156166","article-title":"Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond","volume":"145","author":"Liu","year":"2018","journal-title":"Development"},{"issue":"130","key":"10.1016\/j.yjmcc.2025.09.008_bb1010","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003552","article-title":"Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy","volume":"4","author":"Sun","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb1015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.stem.2015.04.020","article-title":"Epigenetic regulation of Phosphodiesterases 2A and 3A underlies compromised \u03b2-adrenergic signaling in an iPSC model of dilated cardiomyopathy","volume":"17","author":"Wu","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb1020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"554","key":"10.1016\/j.yjmcc.2025.09.008_bb1025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax9276","article-title":"Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy","volume":"12","author":"Sayed","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.09.008_bb1030","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.celrep.2014.09.055","article-title":"Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells","volume":"9","author":"Drawnel Faye","year":"2014","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb1035","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCRESAHA.115.303810","article-title":"Human induced pluripotent stem cell\u2013derived cardiomyocytes as an In vitro model for coxsackievirus B3\u2013induced myocarditis and antiviral drug screening platform","volume":"115","author":"Sharma","year":"2014","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb1040","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.stemcr.2019.04.017","article-title":"Using human induced pluripotent stem cell-derived cardiomyocytes as a model to study Trypanosoma cruzi infection","volume":"12","author":"Bozzi","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"255","key":"10.1016\/j.yjmcc.2025.09.008_bb1045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009027","article-title":"Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system","volume":"6","author":"Ebert","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"377","key":"10.1016\/j.yjmcc.2025.09.008_bb1050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2584","article-title":"High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells","volume":"9","author":"Sharma","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"21","key":"10.1016\/j.yjmcc.2025.09.008_bb1055","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.118.037357","article-title":"Human-induced pluripotent stem cell model of Trastuzumab-induced cardiac dysfunction in patients with breast Cancer","volume":"139","author":"Kitani","year":"2019","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.yjmcc.2025.09.008_bb1060","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/eurheartj\/ehx811","article-title":"Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it?","volume":"40","author":"Stack","year":"2018","journal-title":"Eur. Heart J."},{"issue":"14","key":"10.1016\/j.yjmcc.2025.09.008_bb1065","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/cvr\/cvaa267","article-title":"SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes","volume":"116","author":"Bojkova","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb1070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.actbio.2019.05.016","article-title":"Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications","volume":"92","author":"Goldfracht","year":"2019","journal-title":"Acta Biomater."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb1075","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/nprot.2017.033","article-title":"Differentiation of cardiomyocytes and generation of human engineered heart tissue","volume":"12","author":"Breckwoldt","year":"2017","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.09.008_bb1080","first-page":"331","article-title":"SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis","volume":"6","author":"Bailey","year":"2021","journal-title":"JACC: Basic Transl. Sci."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.09.008_bb1085","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.stemcr.2021.07.012","article-title":"Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2","volume":"16","author":"Yang","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb1090","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13428","article-title":"Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: a systematic review","volume":"51","author":"Malaty","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.09.008_bb1095","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/term.3327","article-title":"Human cardiac organoids to model COVID-19 cytokine storm induced cardiac injuries","volume":"16","author":"Arhontoulis","year":"2022","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb1100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.607364","article-title":"Building multi-dimensional induced pluripotent stem cells-based model platforms to assess cardiotoxicity in cancer therapies","volume":"12","author":"Thomas","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb1105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12872-022-02543-7","article-title":"An evidence appraisal of heart organoids in a dish and commensurability to human heart development in vivo","volume":"22","author":"Thomas","year":"2022","journal-title":"BMC Cardiovasc. Disord."},{"issue":"13","key":"10.1016\/j.yjmcc.2025.09.008_bb1110","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk0164","article-title":"Cardiac tissue model of immune-induced dysfunction reveals the role of free mitochondrial DNA and the therapeutic effects of exosomes","volume":"10","author":"Lu","year":"2024","journal-title":"Sci. Adv."},{"issue":"497","key":"10.1016\/j.yjmcc.2025.09.008_bb1115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav1386","article-title":"Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics","volume":"11","author":"McAleer","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ooc.2021.100008","article-title":"Heart\/liver-on-a-chip as a model for the evaluation of cardiotoxicity induced by chemotherapies","volume":"3","author":"Soltantabar","year":"2021","journal-title":"Organs-on-a-Chip"},{"issue":"8","key":"10.1016\/j.yjmcc.2025.09.008_bb1125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41578-018-0034-7","article-title":"Advances in organ-on-a-chip engineering","volume":"3","author":"Zhang","year":"2018","journal-title":"Nat. Rev. Mater."},{"issue":"15","key":"10.1016\/j.yjmcc.2025.09.008_bb1130","article-title":"A heart-breast cancer-on-a-chip platform for disease modeling and monitoring of cardiotoxicity induced by Cancer chemotherapy","volume":"17","author":"Lee","year":"2021","journal-title":"Small"},{"issue":"8","key":"10.1016\/j.yjmcc.2025.09.008_bb1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113003","article-title":"Integrative approaches in cardiac tissue engineering: bridging cellular complexity to create accurate physiological models","volume":"28","author":"Thomas","year":"2025","journal-title":"iScience"},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb1140","article-title":"Combined use of electrocardiography and ultrasound to detect cardiac and pulmonary involvement after recovery from COVID-19 pneumonia: a case series","volume":"8","author":"Marazzato","year":"2021","journal-title":"J Cardiovasc Dev Dis."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.09.008_bb1145","article-title":"Harnessing electronic health records and artificial intelligence for enhanced cardiovascular risk prediction: a comprehensive review","volume":"14","author":"Tsai","year":"2025","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.09.008_bb1150","article-title":"The role of AI in hospitals and clinics: transforming healthcare in the 21st century","volume":"11","author":"Maleki Varnosfaderani","year":"2024","journal-title":"Bioengineering (Basel)"},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb1155","doi-asserted-by":"crossref","DOI":"10.7861\/fhj.2021-0095","article-title":"Artificial intelligence in healthcare: transforming the practice of medicine","volume":"8","author":"Bajwa","year":"2021","journal-title":"Future Healthc J."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102210","article-title":"Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study","volume":"64","author":"Dagliati","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb1165","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41746-024-01286-3","article-title":"Finding Long-COVID: temporal topic modeling of electronic health records from the N3C and RECOVER programs","volume":"7","author":"O\u2019Neil","year":"2024","journal-title":"npj Digit. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb1170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41591-022-02130-5","article-title":"Machine learning identifies long COVID patterns from electronic health records","volume":"29","year":"2023","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.yjmcc.2025.09.008_bb1175","doi-asserted-by":"crossref","DOI":"10.1016\/S2589-7500(22)00048-6","article-title":"Identifying who has long COVID in the USA: a machine learning approach using N3C data","volume":"4","author":"Pfaff","year":"2022","journal-title":"Lancet Digital Health."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb1180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12911-024-02745-3","article-title":"Machine learning predicts pulmonary Long Covid sequelae using clinical data","volume":"24","author":"Cordelli","year":"2024","journal-title":"BMC Med. Inform. Decis. Mak."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb1185","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41591-022-02116-3","article-title":"Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes","volume":"29","author":"Zhang","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb1190","doi-asserted-by":"crossref","DOI":"10.1038\/s41390-025-03837-0","article-title":"Distinct pro-inflammatory\/pro-angiogenetic signatures distinguish children with Long COVID from controls","author":"Buonsenso","year":"2025","journal-title":"Pediatr. Res."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.09.008_bb1195","article-title":"Vascular implications of COVID-19: role of radiological imaging, artificial intelligence, and tissue characterization: a special report","volume":"9","author":"Khanna","year":"2022","journal-title":"J Cardiovasc Dev Dis."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb1200","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCRESAHA.122.321882","article-title":"Multimodality cardiac imaging in COVID","volume":"132","author":"Holby","year":"2023","journal-title":"Circ. Res."},{"issue":"10228","key":"10.1016\/j.yjmcc.2025.09.008_bb1205","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30558-4","article-title":"Comorbidities and multi-organ injuries in the treatment of COVID-19","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"issue":"6585","key":"10.1016\/j.yjmcc.2025.09.008_bb1210","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.abm8108","article-title":"The immunology and immunopathology of COVID-19","volume":"375","author":"Merad","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb1215","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/07853890.2022.2076901","article-title":"Pathophysiology and mechanism of long COVID: a comprehensive review","volume":"54","author":"Castanares-Zapatero","year":"2022","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb1220","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"23","author":"Mehandru","year":"2022","journal-title":"Nat. Immunol."},{"issue":"6725","key":"10.1016\/j.yjmcc.2025.09.008_bb1225","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1126\/science.add2962","article-title":"Endothelial inflammation in COVID-19","volume":"386","author":"Libby","year":"2024","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.yjmcc.2025.09.008_bb1230","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41591-022-02156-9","article-title":"Comorbidities, multimorbidity and COVID-19","volume":"29","author":"Russell","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2025.09.008_bb1235","article-title":"Sex differences in symptomatology and immune profiles of long COVID","author":"Silva","year":"2024","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb1240","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12916-021-02222-y","article-title":"Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core outcome set development","volume":"20","author":"Munblit","year":"2022","journal-title":"BMC Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.09.008_bb1245","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1161\/CIRCRESAHA.122.321877","article-title":"Microfluidic organ-chips and stem cell models in the fight against COVID-19","volume":"132","author":"Satta","year":"2023","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.09.008_bb1250","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1080\/22221751.2022.2133639","article-title":"Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study","volume":"11","author":"Li","year":"2022","journal-title":"Emerg. Microbes Infect."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282825001786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282825001786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:13:35Z","timestamp":1763698415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282825001786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":250,"alternative-id":["S0022282825001786"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2025.09.008","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding long COVID-associated cardiovascular dysfunction: Mechanisms, models, and new approach methodologies","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2025.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}